Cliff Asness's CRDF Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 346,353 shares of Cardiff Oncology, Inc. (CRDF) worth $450,260, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in CRDF, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 330,006 shares. Largest reduction occurred in Q2 2022, reducing 308,703 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Cardiff Oncology (CRDF) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cardiff Oncology (CRDF) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +280,197 | Add 423.54% | 346,353 | $1.30 |
| Q1 2026 | +66,156 | New Buy | 66,156 | $1.62 |
| Q4 2025 | -48,281 | Sold Out | 0 | $0.00 |
| Q3 2025 | +29,360 | Add 155.17% | 48,281 | $2.06 |
| Q2 2025 | -10,262 | Reduce 35.16% | 18,921 | $3.15 |
| Q1 2025 | -11,456 | Reduce 28.19% | 29,183 | $3.14 |
| Q4 2024 | +9,770 | Add 31.65% | 40,639 | $4.34 |
| Q3 2024 | +30,869 | New Buy | 30,869 | $2.67 |
| Q3 2022 | -54,580 | Sold Out | 0 | $0.00 |
| Q2 2022 | -308,703 | Reduce 84.98% | 54,580 | $2.20 |
| Q1 2022 | +330,006 | Add 991.69% | 363,283 | $2.48 |
| Q4 2021 | -2,776 | Reduce 7.70% | 33,277 | $6.01 |
| Q3 2021 | +36,053 | New Buy | 36,053 | $6.66 |
Cliff Asness's Cardiff Oncology Investment FAQs
Cliff Asness first purchased Cardiff Oncology, Inc. (CRDF) in Q3 2021, acquiring 36,053 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Cardiff Oncology, Inc. (CRDF) for 13 quarters since Q3 2021.
Cliff Asness's largest addition to Cardiff Oncology, Inc. (CRDF) was in Q1 2022, adding 363,283 shares worth $901,000.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 346,353 shares of Cardiff Oncology, Inc. (CRDF), valued at approximately $450,260.
As of the Q2 2026 filing, Cardiff Oncology, Inc. (CRDF) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Cardiff Oncology, Inc. (CRDF) was 363,283 shares, as reported at the end of Q1 2022.